首页 > 最新文献

Reviews on Clinical Pharmacology and Drug Therapy最新文献

英文 中文
Modern representations about signaling pathways and protective mechanisms of ferroptosis. A biological role of diffusion of death signals of ferroptotic cells 铁下垂的信号通路及保护机制的现代研究进展。嗜铁细胞死亡信号扩散的生物学作用
Pub Date : 2023-10-10 DOI: 10.17816/rcf567780
Vladimir I. Vashchenko, Elena F. Sorocoletova, Petr D. Shabanov
Ferroptosis as the type nonapoptosis adjustable destruction of cells arises and develops by means of difficult signals and regulatory mechanisms. The reactive oxygen species (ROS) used to initiate ferroptosis come from a variety of sources, including iron-mediated Fenton reactions, mitochondrial ROS, and membrane-associated ROS driven by the NOX protein family. Polyunsaturated fatty acid-containing phospholipids are the main substrates of lipid peroxidation in ferroptosis, which is positively regulated by enzymes, such as ACSL4, LPCAT3, ALOXs, or POR. Selective activation of autophagic degradation pathways promotes ferroptosis by increasing iron accumulation to cause lipid peroxidation. In contrast, system Xc-glutathioneGPX4 axis plays a central role in limiting lipid peroxidation, although other antioxidants (such as coenzyme Q10 and tetrahydrobiopterin) can also inhibit ferroptosis. A main nuclear mechanism of cell defense against ferroptosis is the activation of the NFE2L2-dependent antioxidant response by transcriptionally upregulating the expression of antioxidants or cytoprotective genes. Additionally, the membrane damage caused by ferroptotic stimulus can be repaired by ESCRT-III-dependent membrane scission machinery. In this review, we summarize recent progress in understanding the signaling pathways and defense mechanisms of ferroptosis.
铁凋亡作为一种非凋亡可调节的细胞破坏,通过复杂的信号和调控机制发生和发展。用于引发铁死亡的活性氧(ROS)有多种来源,包括铁介导的芬顿反应、线粒体ROS和由NOX蛋白家族驱动的膜相关ROS。含多不饱和脂肪酸的磷脂是铁下垂中脂质过氧化的主要底物,这一过程受到ACSL4、LPCAT3、ALOXs或POR等酶的正向调节。选择性激活自噬降解途径通过增加铁积累引起脂质过氧化促进铁下垂。相比之下,系统xc -谷胱甘肽egpx4轴在限制脂质过氧化中起核心作用,尽管其他抗氧化剂(如辅酶Q10和四氢生物terin)也可以抑制铁下垂。细胞防御铁凋亡的主要核机制是通过转录上调抗氧化剂或细胞保护基因的表达来激活nfe2l2依赖的抗氧化反应。此外,由高铁刺激引起的膜损伤可以通过escrt - iii依赖的膜断裂机制修复。本文就铁下垂的信号通路和防御机制的研究进展作一综述。
{"title":"Modern representations about signaling pathways and protective mechanisms of ferroptosis. A biological role of diffusion of death signals of ferroptotic cells","authors":"Vladimir I. Vashchenko, Elena F. Sorocoletova, Petr D. Shabanov","doi":"10.17816/rcf567780","DOIUrl":"https://doi.org/10.17816/rcf567780","url":null,"abstract":"Ferroptosis as the type nonapoptosis adjustable destruction of cells arises and develops by means of difficult signals and regulatory mechanisms. The reactive oxygen species (ROS) used to initiate ferroptosis come from a variety of sources, including iron-mediated Fenton reactions, mitochondrial ROS, and membrane-associated ROS driven by the NOX protein family. Polyunsaturated fatty acid-containing phospholipids are the main substrates of lipid peroxidation in ferroptosis, which is positively regulated by enzymes, such as ACSL4, LPCAT3, ALOXs, or POR. Selective activation of autophagic degradation pathways promotes ferroptosis by increasing iron accumulation to cause lipid peroxidation. In contrast, system Xc-glutathioneGPX4 axis plays a central role in limiting lipid peroxidation, although other antioxidants (such as coenzyme Q10 and tetrahydrobiopterin) can also inhibit ferroptosis. A main nuclear mechanism of cell defense against ferroptosis is the activation of the NFE2L2-dependent antioxidant response by transcriptionally upregulating the expression of antioxidants or cytoprotective genes. Additionally, the membrane damage caused by ferroptotic stimulus can be repaired by ESCRT-III-dependent membrane scission machinery. In this review, we summarize recent progress in understanding the signaling pathways and defense mechanisms of ferroptosis.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136352418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical manifestations and mechanisms of formation of neurological disorders in patients with vibration disease 振动病患者神经功能障碍的临床表现及形成机制
Pub Date : 2023-10-10 DOI: 10.17816/rcf567786
Victoria V. Vorobieva, Olga S. Levchenkova
The review presents an analysis of literature sources devoted to the study of changes in the nervous system in patients with vibration disease. Vibration-mediated cellular hypoxia, which occurs as a result of spastic changes in blood vessels, phase fluctuations in intravascular pressure, impaired blood and lymph outflow, causes suppression of energy metabolism, contributes to disorders at the level of receptor (glutamate, GABA-ergic, dopamine and cholinergic) and synaptic structures, conductors of pain and temperature sensitivity (demyelinization), analyzing neurons in the parietal region of the brain, regulatory proteins of the nervous tissue (NF-200, GFAP S-100). A low-amplitude, irregular, disorganized and sometimes deformed EEG spectrum with a predominance of the alpha wave and a shift of the alpha rhythm to the left reflects changes in the spontaneous electrical activity of brain structures in patients. With an increase in the experience dose of vibration-noise exposure, the dominant alpha activity changes to slow-wave or polyrhythmic. Mild and moderate diffuse changes in the brain become focal in nature, cortical-subcortical relationships are disrupted at the diencephalic level, creating a pathophysiological basis for sensorineural (sensory-neural) hearing loss, especially in patients with a genetic predisposition mediated by genes encoding proteins of the heat shock system. The psycho-emotional status of patients is characterized by a hypochondriacal focus on the state of health, mental disadaptation, psycho-emotional disorders in the form of anxiety, depressive mood. The analysis of literature sources on the mechanisms of the formation of neurological disorders in patients with vibration disease revealed the lack of data on the state of the multicomponent ghrelin system interacting with GHSR-1A and GHSR-1B receptors, which determines a new vector in further experimental and clinical studies.
本综述分析了有关振动病患者神经系统变化研究的文献资料。振动介导的细胞缺氧是由于血管痉挛变化、血管内压力相位波动、血液和淋巴流出受损而发生的,导致能量代谢受到抑制,导致受体(谷氨酸、氨基丁酸能、多巴胺和胆碱能)和突触结构、疼痛和温度敏感性传导(脱髓鞘)水平紊乱,分析大脑顶叶区域的神经元,神经组织的调节蛋白(NF-200, GFAP S-100)。低振幅、不规则、无序、有时变形的脑电图频谱,以α波为主,α节奏向左移动,反映了患者脑结构自发电活动的变化。随着振动噪声暴露体验剂量的增加,主导α活动转变为慢波或多节奏。大脑轻度和中度弥漫性变化在本质上成为局灶性变化,皮层-皮层下关系在间脑水平被破坏,为感觉神经(感觉神经)听力损失创造了病理生理基础,特别是在由编码热休克系统蛋白质的基因介导的遗传易感性患者中。患者的心理情绪状态的特点是对健康状况的疑病症关注,精神上的不适应,以焦虑、抑郁情绪的形式出现的心理情绪障碍。通过对振动病患者神经系统疾病形成机制的文献来源分析,发现缺乏GHSR-1A和GHSR-1B受体相互作用的多组分ghrelin系统状态的数据,这为进一步的实验和临床研究确定了新的载体。
{"title":"Clinical manifestations and mechanisms of formation of neurological disorders in patients with vibration disease","authors":"Victoria V. Vorobieva, Olga S. Levchenkova","doi":"10.17816/rcf567786","DOIUrl":"https://doi.org/10.17816/rcf567786","url":null,"abstract":"The review presents an analysis of literature sources devoted to the study of changes in the nervous system in patients with vibration disease. Vibration-mediated cellular hypoxia, which occurs as a result of spastic changes in blood vessels, phase fluctuations in intravascular pressure, impaired blood and lymph outflow, causes suppression of energy metabolism, contributes to disorders at the level of receptor (glutamate, GABA-ergic, dopamine and cholinergic) and synaptic structures, conductors of pain and temperature sensitivity (demyelinization), analyzing neurons in the parietal region of the brain, regulatory proteins of the nervous tissue (NF-200, GFAP S-100). A low-amplitude, irregular, disorganized and sometimes deformed EEG spectrum with a predominance of the alpha wave and a shift of the alpha rhythm to the left reflects changes in the spontaneous electrical activity of brain structures in patients. With an increase in the experience dose of vibration-noise exposure, the dominant alpha activity changes to slow-wave or polyrhythmic. Mild and moderate diffuse changes in the brain become focal in nature, cortical-subcortical relationships are disrupted at the diencephalic level, creating a pathophysiological basis for sensorineural (sensory-neural) hearing loss, especially in patients with a genetic predisposition mediated by genes encoding proteins of the heat shock system. The psycho-emotional status of patients is characterized by a hypochondriacal focus on the state of health, mental disadaptation, psycho-emotional disorders in the form of anxiety, depressive mood. The analysis of literature sources on the mechanisms of the formation of neurological disorders in patients with vibration disease revealed the lack of data on the state of the multicomponent ghrelin system interacting with GHSR-1A and GHSR-1B receptors, which determines a new vector in further experimental and clinical studies.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"2015 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136294935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of osteogenesis processes against the background of experimental osteoporosis therapy 实验性骨质疏松治疗背景下的成骨过程评价
Pub Date : 2023-10-10 DOI: 10.17816/rcf567788
Alekber A. Bayramov, Nailya Sh. Mamina, Dmitriy А. Lisovskiy, Nikita A. Fedorov, Tatiana L. Karonova, Petr D. Shabanov
Background. Osteoporosis is a problem all over the world with important clinical and economic consequences. A significant contribution to solving the problem of the spread of osteoporosis can be the creation of drugs based on unique biologically active compounds. The aim was to evaluate the processes of osteogenesis, according to the formation of an organic matrix of bone tissue, as well as to evaluate markers of bone remodeling in blood serum at the stages of anti-osteoporosis therapy. Materials and methods. The study was performed on an experimental model of osteoporosis using biochemical methods for analyzing markers of osteoporosis in blood serum, as well as atomic absorption spectroscopy and X-ray densitometry. Results. According to the results of the study, the specific anti-osteoporotic activity of the new drug based on succinic acid salts was proved - a significant increase in the organic component the total collagen in bone tissue and the mineral component - the main elements in bone tissue in both young and old senile animals. Evaluation of the dynamics of the content of markers of bone remodeling showed the high effectiveness of the new drug in monotherapy, and in combination with vitamin D3 in the activation of osteogenesis processes in experimental osteoporosis. Conclusion. The effectiveness of the proposed anti-osteoporotic agent is shown, which is more pronounced in senile rats and is due to a proportional increase in the organic and mineral components of bone tissue.
背景。骨质疏松症是一个全球性的问题,具有重要的临床和经济后果。解决骨质疏松症扩散问题的一个重要贡献可能是基于独特生物活性化合物的药物的创造。目的是根据骨组织有机基质的形成来评估骨生成过程,以及评估抗骨质疏松治疗阶段血清中骨重塑的标志物。 材料和方法。采用生化方法分析血清骨质疏松标志物,原子吸收光谱和x射线密度测定,建立骨质疏松实验模型。 结果。研究结果表明,以琥珀酸盐为基础的新药具有特异性的抗骨质疏松活性,其骨组织中总胶原蛋白的有机成分和骨组织中主要元素的矿物质成分均显著增加。对骨重塑标志物含量的动态评价表明,新药在单药治疗和与维生素D3联合治疗中对实验性骨质疏松症的成骨过程具有较高的激活作用。 结论。所提出的抗骨质疏松剂的有效性得到了证明,这在老年大鼠中更为明显,这是由于骨组织中有机和矿物质成分的比例增加。
{"title":"Evaluation of osteogenesis processes against the background of experimental osteoporosis therapy","authors":"Alekber A. Bayramov, Nailya Sh. Mamina, Dmitriy А. Lisovskiy, Nikita A. Fedorov, Tatiana L. Karonova, Petr D. Shabanov","doi":"10.17816/rcf567788","DOIUrl":"https://doi.org/10.17816/rcf567788","url":null,"abstract":"Background. Osteoporosis is a problem all over the world with important clinical and economic consequences. A significant contribution to solving the problem of the spread of osteoporosis can be the creation of drugs based on unique biologically active compounds.
 The aim was to evaluate the processes of osteogenesis, according to the formation of an organic matrix of bone tissue, as well as to evaluate markers of bone remodeling in blood serum at the stages of anti-osteoporosis therapy.
 Materials and methods. The study was performed on an experimental model of osteoporosis using biochemical methods for analyzing markers of osteoporosis in blood serum, as well as atomic absorption spectroscopy and X-ray densitometry.
 Results. According to the results of the study, the specific anti-osteoporotic activity of the new drug based on succinic acid salts was proved - a significant increase in the organic component the total collagen in bone tissue and the mineral component - the main elements in bone tissue in both young and old senile animals. Evaluation of the dynamics of the content of markers of bone remodeling showed the high effectiveness of the new drug in monotherapy, and in combination with vitamin D3 in the activation of osteogenesis processes in experimental osteoporosis.
 Conclusion. The effectiveness of the proposed anti-osteoporotic agent is shown, which is more pronounced in senile rats and is due to a proportional increase in the organic and mineral components of bone tissue.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"60 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136293715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological correction of adaptive asthenia in high-class athletes 高水平运动员适应性衰弱的药物矫正
Pub Date : 2023-10-10 DOI: 10.17816/rcf567787
Viktorovna Galina Buznik, Pavel V. Rodichkin
BACKGROUND: Metabolic protectors containing (Mexicor, Cytoflavin, Metaprot Plus) or not containing (Emoxipin, Riboxin, Metaprot) succinate in their structure showed a sufficiently high clinical efficacy in eliminating or reducing the asthenic symptom complex in athletes with overtraining. AIM: The aim of the study was to develop the principles of rational pharmacological correction of asthenic symptom complex in high performance athletes using succinate-free and succinate-containing metabolic protectors (Mexicor, Riboxin/Cytoflavin, Metaprot/Metaprot Plus). MATERIALS AND METHODS: The study included 104 high-class athletes of various specializations, which was conducted during the period of the athletes training camps in the pre-competitive period. Due to the high physical and mental stress in the pre-competition period and the focus on competitive selection for responsible international competitions, a short (15 days) study period was used. The maximum loads in athletes were achieved by the end of the 7th day of training, followed by stabilization of the loads and its optimization by the 15th day. The work was performed in compliance with all the rules of evidence-based medicine and ethical standards of work (obtaining informed consent, randomization, the use of a double-blind placebo-controlled method of treatment, valid methods of statistical evaluation). RESULTS: The course prescription of succinate-containing metabolic protectors during the period of preparation for competitions had a favorable effect on the restoration of high functional indicators, which is confirmed by an objective assessment of the functional state of athletes, data from biochemical studies of metabolism (carbohydrate, protein and fat), as well as the oxidative status of athletes. In the groups of athletes who received metabolic protectors, recovery was more active than in the placebo group, this was especially noticeable in the groups that received Metaprot plus, Metaprot and Сytoflavin, to a lesser extent Мexicor and Riboxin. In the latter case, the indicators in the stress tests of Stange and Gench were not fully restored, which was also reflected in the reduced Bogomazov index. It is important to emphasize that the indicators of physical endurance (PWC170) reached the values of the initial period, which indicates the optimization of loads under the influence of metabolic agents. CONCLUSIONS: The most effective in restoring the functional state of high-class athletes are succinate-containing metabolic agents (Metaprot plus, Cytoflavin, Mexicor) and to a lesser extent (in comparison with them) drugs that do not contain succinic acid (Riboxin, partly Metaprot). LPO indicators, initially somewhat elevated in athletes, showed a tendency to normalize under the influence of the appointment of metabolic protectors. Almost all studied preparations showed activity according to these tests, although the most pronounced positive changes were registered aft
背景:结构中含有(Mexicor, Cytoflavin, Metaprot Plus)或不含(Emoxipin, Riboxin, Metaprot)琥珀酸盐的代谢保护剂在消除或减轻过度训练运动员的虚弱症状复现方面表现出足够高的临床疗效。目的:本研究的目的是制定使用无琥珀酸和含琥珀酸代谢保护剂(Mexicor、Riboxin/Cytoflavin、Metaprot/Metaprot Plus)合理药物纠正高性能运动员虚弱症状复合物的原则。材料与方法:研究对象为104名各专业高水平运动员,在赛前运动员训练营期间进行。由于赛前体能和精神压力较大,以及注重负责任的国际比赛的竞技选拔,研究周期较短(15天)。运动员在训练第7天结束时达到最大负荷,随后在第15天达到负荷稳定和优化。本研究遵循循证医学的所有规则和工作的伦理标准(获得知情同意、随机分组、采用双盲安慰剂对照的治疗方法、有效的统计评价方法)。 结果:在备战期间给予含琥珀酸代谢保护剂的疗程处方,对运动员高功能指标的恢复有良好的效果,这一结果得到了运动员功能状态客观评价、代谢生化研究(碳水化合物、蛋白质和脂肪)数据以及运动员氧化状态的证实。在接受代谢保护剂的运动员组中,恢复比安慰剂组更活跃,这在接受Metaprot +, Metaprot和Сytoflavin的组中尤其明显,在较小程度上Мexicor和Riboxin。在后一种情况下,Stange和Gench的压力测试指标没有完全恢复,这也反映在Bogomazov指数的下降上。需要强调的是,体力耐力指标(PWC170)达到了初始阶段的值,这表明在代谢剂的影响下,负荷得到了优化。 结论:高水平运动员恢复功能状态最有效的药物是含琥珀酸代谢药物(Metaprot +、Cytoflavin、Mexicor),而不含琥珀酸的药物(Riboxin、部分Metaprot)作用较小(与之相比)。LPO指标最初在运动员中有所升高,但在代谢保护剂的作用下呈现出正常化的趋势。根据这些测试,几乎所有研究的制剂都显示出活性,尽管最明显的积极变化是在指定Мetaprot +、Мetaprot和Сytoflavin之后发生的。在所有研究参数中,墨西哥和核糖素的活性都有所降低。
{"title":"Pharmacological correction of adaptive asthenia in high-class athletes","authors":"Viktorovna Galina Buznik, Pavel V. Rodichkin","doi":"10.17816/rcf567787","DOIUrl":"https://doi.org/10.17816/rcf567787","url":null,"abstract":"BACKGROUND: Metabolic protectors containing (Mexicor, Cytoflavin, Metaprot Plus) or not containing (Emoxipin, Riboxin, Metaprot) succinate in their structure showed a sufficiently high clinical efficacy in eliminating or reducing the asthenic symptom complex in athletes with overtraining.
 AIM: The aim of the study was to develop the principles of rational pharmacological correction of asthenic symptom complex in high performance athletes using succinate-free and succinate-containing metabolic protectors (Mexicor, Riboxin/Cytoflavin, Metaprot/Metaprot Plus).
 MATERIALS AND METHODS: The study included 104 high-class athletes of various specializations, which was conducted during the period of the athletes training camps in the pre-competitive period. Due to the high physical and mental stress in the pre-competition period and the focus on competitive selection for responsible international competitions, a short (15 days) study period was used. The maximum loads in athletes were achieved by the end of the 7th day of training, followed by stabilization of the loads and its optimization by the 15th day. The work was performed in compliance with all the rules of evidence-based medicine and ethical standards of work (obtaining informed consent, randomization, the use of a double-blind placebo-controlled method of treatment, valid methods of statistical evaluation).
 RESULTS: The course prescription of succinate-containing metabolic protectors during the period of preparation for competitions had a favorable effect on the restoration of high functional indicators, which is confirmed by an objective assessment of the functional state of athletes, data from biochemical studies of metabolism (carbohydrate, protein and fat), as well as the oxidative status of athletes. In the groups of athletes who received metabolic protectors, recovery was more active than in the placebo group, this was especially noticeable in the groups that received Metaprot plus, Metaprot and Сytoflavin, to a lesser extent Мexicor and Riboxin. In the latter case, the indicators in the stress tests of Stange and Gench were not fully restored, which was also reflected in the reduced Bogomazov index. It is important to emphasize that the indicators of physical endurance (PWC170) reached the values of the initial period, which indicates the optimization of loads under the influence of metabolic agents.
 CONCLUSIONS: The most effective in restoring the functional state of high-class athletes are succinate-containing metabolic agents (Metaprot plus, Cytoflavin, Mexicor) and to a lesser extent (in comparison with them) drugs that do not contain succinic acid (Riboxin, partly Metaprot). LPO indicators, initially somewhat elevated in athletes, showed a tendency to normalize under the influence of the appointment of metabolic protectors. Almost all studied preparations showed activity according to these tests, although the most pronounced positive changes were registered aft","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136295368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical-chemical repurposing of drugs. History of its formation in Russia 药物的物理化学再利用。它在俄罗斯的形成历史
Pub Date : 2023-10-10 DOI: 10.17816/rcf567782
Aleksandr L. Urakov, Petr D. Shabanov
It is reported that the traditional scheme of finding and developing a new drug and conducting the whole complex of preclinical studies requires several thousand chemical compounds, hundreds of millions of US dollars and more than 12 years of work. It is shown that physicochemical pharmacology was born in Russia at the end of the 20th century, which in our days has been transformed into physicochemical repurposing of known medicines. The first successfully repurposed known drug was a solution of 4% potassium chloride, which had previously traditionally belonged to the group of macro- and microelements, used by intravenous injections to regulate acid-base balance and rhythmic activity of the heart. In 1983, it was stated that this medicinal solution, when heated to 3942C and applied topically by irrigation of the bleeding surface, could be classified as a vasoconstrictor and hemostatic drug. Hyperthermia was used as a physico-chemical reprofiling factor, which, according to the Arrhenius law, accelerated and intensified, on the one hand, the spastic action of K+ cations on the gaping blood vessels (formation of hyperkalium contracture in the smooth muscles of the vascular wall) and, on the other hand, the blood clotting process in the wound. In subsequent years, the promise of physicochemical repurposing of known drugs was shown on the example of water, hydrogen peroxide, sodium chloride and sodium bicarbonate by purposefully changing their temperature, acid, osmotic activity, as well as the amount and quality of gas content (passing). A chronology of the physicochemical repurposing of known drug solutions and tablets is described and the essence of such new groups of drugs as bleachers of bruises and pyolytics is given. It is shown that both groups of drugs were discovered in Russia and are intended for local use to bleach bruises (blood stains) and dissolve thick mucus, sputum, pus, blood clots, meconium and other dense biological tissues containing the enzyme catalase. It is pointed out that the advantage and at the same time the limitation of the known drugs repurposed according to this scheme is their local application, since their new pharmacological activity is caused mainly by the physical and chemical principle of action, which is manifested by local interaction with the selected area of the patients organism.
据报道,传统的发现和开发一种新药并进行整个临床前研究的方案需要数千种化合物,数亿美元和12年以上的工作。物化药理学诞生于20世纪末的俄罗斯,在我们的时代已经转变为对已知药物的物化再利用。第一个成功改造用途的已知药物是一种含有4%氯化钾的溶液,这种药物以前传统上属于常量和微量元素,通过静脉注射来调节酸碱平衡和心脏节律性活动。1983年,有人指出,这种药液加热到3942℃,局部冲洗出血表面,可归类为血管收缩剂和止血药物。热疗作为一种理化重构因子,根据阿伦尼乌斯定律,热疗一方面加速和加强了K+阳离子对张开的血管的痉挛作用(血管壁平滑肌形成高钾挛缩),另一方面加速和加强了伤口中的血液凝固过程。在随后的几年里,以水、过氧化氢、氯化钠和碳酸氢钠为例,通过有目的地改变它们的温度、酸度、渗透活性以及气体含量(通过)的数量和质量,表明了对已知药物进行物理化学再利用的希望。描述了已知药物溶液和片剂的物理化学重新利用的年表,并给出了诸如瘀伤和溶血剂等新药物组的本质。研究表明,这两组药物都是在俄罗斯发现的,用于当地漂白瘀伤(血迹),溶解粘稠的粘液、痰、脓、血块、胎粪和其他含有过氧化氢酶的致密生物组织。指出根据该方案重新利用的已知药物的优点同时也存在局限性,因为它们的新药理活性主要是由作用的物理和化学原理引起的,表现为与患者机体选定区域的局部相互作用。
{"title":"Physical-chemical repurposing of drugs. History of its formation in Russia","authors":"Aleksandr L. Urakov, Petr D. Shabanov","doi":"10.17816/rcf567782","DOIUrl":"https://doi.org/10.17816/rcf567782","url":null,"abstract":"It is reported that the traditional scheme of finding and developing a new drug and conducting the whole complex of preclinical studies requires several thousand chemical compounds, hundreds of millions of US dollars and more than 12 years of work. It is shown that physicochemical pharmacology was born in Russia at the end of the 20th century, which in our days has been transformed into physicochemical repurposing of known medicines. The first successfully repurposed known drug was a solution of 4% potassium chloride, which had previously traditionally belonged to the group of macro- and microelements, used by intravenous injections to regulate acid-base balance and rhythmic activity of the heart. In 1983, it was stated that this medicinal solution, when heated to 3942C and applied topically by irrigation of the bleeding surface, could be classified as a vasoconstrictor and hemostatic drug. Hyperthermia was used as a physico-chemical reprofiling factor, which, according to the Arrhenius law, accelerated and intensified, on the one hand, the spastic action of K+ cations on the gaping blood vessels (formation of hyperkalium contracture in the smooth muscles of the vascular wall) and, on the other hand, the blood clotting process in the wound. In subsequent years, the promise of physicochemical repurposing of known drugs was shown on the example of water, hydrogen peroxide, sodium chloride and sodium bicarbonate by purposefully changing their temperature, acid, osmotic activity, as well as the amount and quality of gas content (passing). A chronology of the physicochemical repurposing of known drug solutions and tablets is described and the essence of such new groups of drugs as bleachers of bruises and pyolytics is given. It is shown that both groups of drugs were discovered in Russia and are intended for local use to bleach bruises (blood stains) and dissolve thick mucus, sputum, pus, blood clots, meconium and other dense biological tissues containing the enzyme catalase. It is pointed out that the advantage and at the same time the limitation of the known drugs repurposed according to this scheme is their local application, since their new pharmacological activity is caused mainly by the physical and chemical principle of action, which is manifested by local interaction with the selected area of the patients organism.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136294934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A STUDY OF THE EFFECTS OF MAMMALIAN KISSPEPTIN ANALOGUES AND KISSPEPTIN 10 IN DANIO RERIO 哺乳动物kisspeptin类似物和kisspeptin 10在小鼠免疫中的作用研究
Pub Date : 2023-07-15 DOI: 10.17816/rcf321976
V. A. Goltz, A. Lebedev
The neuropeptide kisspeptin is currently most widely known as a regulator of mammalian sexual behavior. For pharmacological analysis, mammalian Kiss1 kisspeptin analogues were used, Clone (USA): KS4, KS5, KS6, KS7, KS8, KS9 and Kiss 10. Kisspeptins were dissolved in aquarium water and applied in two doses: 1). 0.01 mg per 1000 ml of water; 2). 0.1 mg per 1000 ml of water. Phenazepam was dissolved in water and used in three doses: 1) 0.1 mg per 1000 ml of water; 2) 0.5 mg per 1000 ml of water; 3) 1 mg per 1000 ml of water. This paper compares kisspeptines with anxiolytics using phenazepam as an example in the novelty test. It was shown that in response to the novelty of being placed in the viewing tank, fish responded by diving to the bottom, increasing freesing, and decreasing the number of movements to the upper half of the tank. Fish residence time in the lower part of the tank after administration of phenazepepam decreased, especially when used at a dose of 0.5 and 1 mg/liter. Kisspeptin analogues decreased the indices characterizing the anxious state of the fish. Against the background of Kiss1 kisspeptin analogues, the average fish path length differed significantly in contrast to the effects of phenazepam. KS 4 at a dose of 0.1 mg/L showed a 1.4-fold decrease in the number of freesing, 1.4-fold decrease in the freesing time and 1.4-fold decrease in the trajectory length. The number of transitions to the upper part of the tank increased 1.5 times. The dose of 0.01 mg/l decreased the number of freesing by 1.5 times, freesing time by 1.5 times, trajectory length by 3 times. KS 5 at a dose of 0.1 mg/L decreased the number of freesings by a factor of 1.6, the freesing time by a factor of 1.6, and the trajectory length by a factor of 1.17. The number of transitions to the upper part of the tank increased 1.5 times. The dose of 0.01 mg/l decreased the number of freesing by 3 times, freesing time by 2.8 times, trajectory length by 2.8 times. KS 6 at a dose of 0.1 mg/l decreased the number of freesings by 2.7 times, the freesing time by 2 times, and the trajectory length by 2.5 times. The number of transitions to the upper part of the aquarium increased 2.5 times. The dose of 0, 01 mg/ml decreased the number of freesing by 2.6 times, freesing time by 2.6 times, trajectory length by 1.7 times. KS 7 at a dose of 0.1 mg/L decreased the number of freesing by a factor of 1.7, freesing time by a factor of 1.4, and trajectory length by a factor of 1.3. The number of movements to the top of the aquarium increased 1.6-fold. The dose of 0.01 mg/l decreased the number of freesing by 1.7 times, freesing time by 1.4 times, trajectory length by 1.6 times. KS8 at a dose of 0.1 mg/L decreased the number of freesings by 1.6 times, the freesing time by 1.7 times, and the trajectory length by 1.6 times. The dose of 0.01 mg/l decreased the number of freesing by 2.3 times, the freesing time by 2.2 times, and the trajectory length by 1.8 times. KS9 at a dose of 0.1 mg/l
神经肽kisspeptin目前被广泛认为是哺乳动物性行为的调节剂。药理分析采用哺乳动物Kiss1 kisspeptin类似物,克隆(美国):KS4, KS5, KS6, KS7, KS8, KS9和kis10。kisspeptin溶解于水族水中,以两种剂量使用:1)0.01 mg / 1000 ml水;2).每1000毫升水中含0.1毫克。苯那西泮溶于水,分三种剂量使用:1)每1000毫升水0.1 mg;2)每1000毫升水0.5毫克;3)每1000毫升水中含1毫克。本文以苯那西泮为例,在新颖性测试中比较了kisspeptines与抗焦虑药。研究表明,在观看水箱的新奇体验中,鱼的反应是潜入底部,增加自由,减少在水箱上半部分的活动次数。在给予非那西泮后,鱼在鱼缸下部的停留时间减少,特别是当剂量为0.5和1mg /l时。Kisspeptin类似物降低了表征鱼焦虑状态的指数。在Kiss1 kisspeptin类似物的背景下,鱼的平均路径长度与非那西泮的效果有显著差异。ks4在0.1 mg/L剂量下,释放次数减少1.4倍,释放时间减少1.4倍,轨迹长度减少1.4倍。过渡到油箱上部的次数增加了1.5倍。0.01 mg/l剂量使释放次数减少1.5倍,释放时间减少1.5倍,轨迹长度减少3倍。ks5在0.1 mg/L剂量下,释放次数减少1.6倍,释放时间减少1.6倍,轨迹长度减少1.17倍。过渡到油箱上部的次数增加了1.5倍。0.01 mg/l剂量使释放次数减少3倍,释放时间减少2.8倍,轨迹长度减少2.8倍。0.1 mg/l剂量的KS 6使释放次数减少2.7倍,释放时间减少2倍,轨迹长度减少2.5倍。过渡到鱼缸上部的次数增加了2.5倍。0.01 mg/ml剂量使释放次数减少2.6倍,释放时间减少2.6倍,轨迹长度减少1.7倍。ks7在0.1 mg/L剂量下使释放次数减少1.7倍,释放时间减少1.4倍,轨迹长度减少1.3倍。移动到鱼缸顶部的次数增加了1.6倍。0.01 mg/l剂量使释放次数减少1.7倍,释放时间减少1.4倍,轨迹长度减少1.6倍。0.1 mg/L剂量的KS8使释放次数减少1.6倍,释放时间减少1.7倍,轨迹长度减少1.6倍。0.01 mg/l剂量使释放次数减少2.3倍,释放时间减少2.2倍,轨迹长度减少1.8倍。0.1 mg/l剂量的KS9使释放次数减少2.2倍,释放时间减少2.2倍,轨迹长度减少1.2倍。0.01 mg/L剂量使释放次数减少1.5倍,释放时间减少1.5倍,轨迹长度减少1.6倍。在剂量为0.1 mg/L的Kiss 10中,卷曲次数减少1.6倍,冻结时间减少1.5倍,轨迹长度减少1.4倍。向鱼缸上部过渡的次数增加了2.7倍。0.01 mg/l剂量使释放次数减少1.7倍,释放时间减少1.6倍,轨迹长度减少1.3倍。我们观察到轨迹数量增加了1.3倍。综合所获得的指标,我们得出结论,kisspeptin类似物的效果并不逊于服用镇静剂phenazepam后获得的效果。在哺乳动物kisspeptin类似物中,KS6在0.1 mg/L剂量下表现最佳。由此可见,哺乳动物的Kiss1 kisspeptin类似物和kis10可减轻小鼠对新奇事物的焦虑恐惧反应。同时,所研究的kisspeptin类似物的效果低于非那西泮。Kisspeptin不仅参与小鼠5- ht依赖性行为的调节,还作为苯二氮卓类镇静剂参与gaba -能系统。研究结果支持了kisspeptin可能参与调节焦虑恐惧症状态的假设,显然是为了维持生殖行为的情感方面,如性动机和性唤起。
{"title":"A STUDY OF THE EFFECTS OF MAMMALIAN KISSPEPTIN ANALOGUES AND KISSPEPTIN 10 IN DANIO RERIO","authors":"V. A. Goltz, A. Lebedev","doi":"10.17816/rcf321976","DOIUrl":"https://doi.org/10.17816/rcf321976","url":null,"abstract":"The neuropeptide kisspeptin is currently most widely known as a regulator of mammalian sexual behavior. For pharmacological analysis, mammalian Kiss1 kisspeptin analogues were used, Clone (USA): KS4, KS5, KS6, KS7, KS8, KS9 and Kiss 10. Kisspeptins were dissolved in aquarium water and applied in two doses: 1). 0.01 mg per 1000 ml of water; 2). 0.1 mg per 1000 ml of water. Phenazepam was dissolved in water and used in three doses: 1) 0.1 mg per 1000 ml of water; 2) 0.5 mg per 1000 ml of water; 3) 1 mg per 1000 ml of water. This paper compares kisspeptines with anxiolytics using phenazepam as an example in the novelty test. It was shown that in response to the novelty of being placed in the viewing tank, fish responded by diving to the bottom, increasing freesing, and decreasing the number of movements to the upper half of the tank. Fish residence time in the lower part of the tank after administration of phenazepepam decreased, especially when used at a dose of 0.5 and 1 mg/liter. Kisspeptin analogues decreased the indices characterizing the anxious state of the fish. Against the background of Kiss1 kisspeptin analogues, the average fish path length differed significantly in contrast to the effects of phenazepam. KS 4 at a dose of 0.1 mg/L showed a 1.4-fold decrease in the number of freesing, 1.4-fold decrease in the freesing time and 1.4-fold decrease in the trajectory length. The number of transitions to the upper part of the tank increased 1.5 times. The dose of 0.01 mg/l decreased the number of freesing by 1.5 times, freesing time by 1.5 times, trajectory length by 3 times. KS 5 at a dose of 0.1 mg/L decreased the number of freesings by a factor of 1.6, the freesing time by a factor of 1.6, and the trajectory length by a factor of 1.17. The number of transitions to the upper part of the tank increased 1.5 times. The dose of 0.01 mg/l decreased the number of freesing by 3 times, freesing time by 2.8 times, trajectory length by 2.8 times. KS 6 at a dose of 0.1 mg/l decreased the number of freesings by 2.7 times, the freesing time by 2 times, and the trajectory length by 2.5 times. The number of transitions to the upper part of the aquarium increased 2.5 times. The dose of 0, 01 mg/ml decreased the number of freesing by 2.6 times, freesing time by 2.6 times, trajectory length by 1.7 times. KS 7 at a dose of 0.1 mg/L decreased the number of freesing by a factor of 1.7, freesing time by a factor of 1.4, and trajectory length by a factor of 1.3. The number of movements to the top of the aquarium increased 1.6-fold. The dose of 0.01 mg/l decreased the number of freesing by 1.7 times, freesing time by 1.4 times, trajectory length by 1.6 times. KS8 at a dose of 0.1 mg/L decreased the number of freesings by 1.6 times, the freesing time by 1.7 times, and the trajectory length by 1.6 times. The dose of 0.01 mg/l decreased the number of freesing by 2.3 times, the freesing time by 2.2 times, and the trajectory length by 1.8 times. KS9 at a dose of 0.1 mg/l ","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87425938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alkaline hydrogen peroxide solutions with expectorant, pyolytic, mucolytic, haemolytic, oxygen-releasing and decolorising effects 碱性过氧化氢溶液具有祛痰、溶脓、溶粘液、溶血、释氧和脱色作用
Pub Date : 2023-06-14 DOI: 10.17816/rcf492316
Eugeniy L. Fisher, A. Urakov, A. Samorodov, I. Bashirov, P. Shabanov
Abstract. It was shown that the effect of local action of hydrogen peroxide solution on such dense biological masses as pus, mucus, sputum and blood clots depends not only on the concentration of the main ingredient, but also on the alkalinity of the solution as well as on the temperature of the interaction media. In particular, an increase in solution temperature from +24 - +26 to +45 - +55 C and its alkalinity from pH 7.0 to pH 8.4 - 8.5 increases the pyolytic, mucolytic, hemolytic, bleaching and oxygen-releasing activity of hydrogen peroxide solutions. The indicated level of hyperthermia is provided by simple physical heating of the solution, and the indicated level of alkalinity is provided by introducing sodium bicarbonate into it. It has been found out that hyperthermia according to the laws of physics reduces viscosity of biological masses, increases their fluidity, permeability to the antiseptic solution, miscibility and solubility in it as well as increases the rate of chemical, physico-chemical and biochemical processes according to Arrhenius law. In particular, increasing the temperature of interacting media accelerates the process of alkaline saponification of proteins and protein-lipid complexes that form the basis of colloidal biological masses. In addition, hyperthermia accelerates and strengthens the process of enzymatic decomposition of hydrogen peroxide into water and oxygen gas, which takes place under the action of the enzyme catalase, which is always present in most biological masses. At the same time, the released molecular oxygen forms gas bubbles, which simulate the process of cold boiling and due to this "explode" biological masses, turning them into a fluffy white foam. The fact is that oxygen in an alkaline environment oxidizes biological pigments, including hemoglobin and its metabolites of different colors, and discolors them.
摘要结果表明,过氧化氢溶液对脓液、黏液、痰液、血块等致密生物团块的局部作用不仅与主要成分的浓度有关,还与溶液的碱度和相互作用介质的温度有关。特别是,当溶液温度从+24 - +26℃增加到+45 - +55℃,碱度从pH 7.0增加到pH 8.4 - 8.5时,过氧化氢溶液的溶血、溶黏液、溶血、漂白和释氧活性增加。通过对溶液进行简单的物理加热来提供指定的高温水平,通过向溶液中引入碳酸氢钠来提供指定的碱度水平。研究发现,根据物理规律,热疗降低了生物物质的粘度,增加了它们的流动性、对防腐剂溶液的渗透性、在防腐剂溶液中的混溶性和溶解度,并根据阿伦尼乌斯定律加快了化学、物理化学和生化过程的速度。特别是,提高相互作用介质的温度会加速蛋白质和蛋白质-脂质复合物的碱性皂化过程,而蛋白质和脂质复合物是形成胶体生物团块的基础。此外,高温加速并加强了过氧化氢酶分解成水和氧气的过程,这一过程是在过氧化氢酶的作用下进行的,过氧化氢酶总是存在于大多数生物群体中。与此同时,释放的分子氧形成气泡,模拟冷沸腾的过程,由于这种“爆炸”的生物团,把它们变成蓬松的白色泡沫。事实是,碱性环境中的氧气会氧化生物色素,包括血红蛋白及其不同颜色的代谢物,并使其变色。
{"title":"Alkaline hydrogen peroxide solutions with expectorant, pyolytic, mucolytic, haemolytic, oxygen-releasing and decolorising effects","authors":"Eugeniy L. Fisher, A. Urakov, A. Samorodov, I. Bashirov, P. Shabanov","doi":"10.17816/rcf492316","DOIUrl":"https://doi.org/10.17816/rcf492316","url":null,"abstract":"Abstract. It was shown that the effect of local action of hydrogen peroxide solution on such dense biological masses as pus, mucus, sputum and blood clots depends not only on the concentration of the main ingredient, but also on the alkalinity of the solution as well as on the temperature of the interaction media. In particular, an increase in solution temperature from +24 - +26 to +45 - +55 C and its alkalinity from pH 7.0 to pH 8.4 - 8.5 increases the pyolytic, mucolytic, hemolytic, bleaching and oxygen-releasing activity of hydrogen peroxide solutions. The indicated level of hyperthermia is provided by simple physical heating of the solution, and the indicated level of alkalinity is provided by introducing sodium bicarbonate into it. It has been found out that hyperthermia according to the laws of physics reduces viscosity of biological masses, increases their fluidity, permeability to the antiseptic solution, miscibility and solubility in it as well as increases the rate of chemical, physico-chemical and biochemical processes according to Arrhenius law. In particular, increasing the temperature of interacting media accelerates the process of alkaline saponification of proteins and protein-lipid complexes that form the basis of colloidal biological masses. In addition, hyperthermia accelerates and strengthens the process of enzymatic decomposition of hydrogen peroxide into water and oxygen gas, which takes place under the action of the enzyme catalase, which is always present in most biological masses. At the same time, the released molecular oxygen forms gas bubbles, which simulate the process of cold boiling and due to this \"explode\" biological masses, turning them into a fluffy white foam. The fact is that oxygen in an alkaline environment oxidizes biological pigments, including hemoglobin and its metabolites of different colors, and discolors them.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73495665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emotiogenic effects of аntorex, a novel OX1R antagonist, on emotional manifestations of anxiety and compulsiveness in rats 新型OX1R拮抗剂ntorex对大鼠焦虑和强迫情绪表现的情绪原性作用
Pub Date : 2023-06-14 DOI: 10.17816/rcf492319
A. Lebedev, V. V. Lukashkova, A. G. Pshenichnaya, E. Bychkov, V. Lebedev, Vladimir V. Rusanovsky, P. Shabanov
Background. In recent years, the role of orexins and their receptors in the regulation of the emotions, motivations and brain reinforcing systems has been studied. Orexin is an important regulator of the extrahypothalamic system of corticotropin-releasing hormone. This provides grounds for the search for new pharmacological agents for the treatment of phobic spectrum disorders among drugs that modulate orexin regulation. Aim: To analyze the effect of the new OX1R antagonist Antorex on the emotional manifestations of anxiety in rats. Methods. Experiments were performed on 38 Wistar male rats. Behavior was tested in rats; Antorex 1 g/l (or water) with a volume of 20 l (10 l in each nostril) was intranasally administered. To achieve this goal, a battery of behavioral tests was used: elevated plus maze, open field, marble test, intruder-resident test and anxiety-phobic state assessment. Results. In the elevated plus maze test, Antorex showed moderate anxiolytic activity, increasing the time spent in the light arm compared to control animals. In a marble test, after Antorex administration, a decrease in the number of buried balloons was observed, as a reflection of a decrease in the obsessive-compulsive state of anxiety. In the anxiety-phobic state assessment test, a decrease in the avoidance reaction to the action of the hand was registered. In the "open field" test, a decrease in motor activity was observed. Conclusion. The OX1R antagonist Antorex has an anxiolytic and sedative effect reducing compulsive behavior without affecting the communicative activity. The data obtained provide grounds for the development of new approaches to the treatment of phobic spectrum disorders using drugs that modulate orexin regulation.
背景。近年来,人们对食欲素及其受体在调节情绪、动机和大脑强化系统中的作用进行了研究。食欲素是下丘脑外系统促肾上腺皮质激素释放激素的重要调节因子。这为在调节食欲素调节的药物中寻找治疗恐惧症谱系障碍的新药物提供了依据。目的:分析新型OX1R拮抗剂安托雷克斯对大鼠焦虑情绪表现的影响。方法。实验在38只Wistar雄性大鼠身上进行。对大鼠进行行为测试;安托雷克斯1 g/l(或水),体积为20 l(每个鼻孔10 l)经鼻给药。为了实现这一目标,采用了一系列行为测试:高架加迷宫、开阔场地、大理石测试、入侵者居住者测试和焦虑恐惧状态评估。结果。在升高的迷宫测试中,Antorex表现出适度的抗焦虑活性,与对照动物相比,在轻臂上花费的时间增加了。在一项大理石测试中,在安托雷克斯服用后,被埋气球的数量减少了,这反映了强迫症焦虑状态的减少。在焦虑-恐惧状态评估测试中,对手部动作的回避反应有所减少。在“空地”试验中,观察到运动活动减少。结论。OX1R拮抗剂Antorex具有抗焦虑和镇静作用,在不影响交际活动的情况下减少强迫行为。获得的数据为开发使用调节食欲素调节的药物治疗恐惧症谱系障碍的新方法提供了依据。
{"title":"Emotiogenic effects of аntorex, a novel OX1R antagonist, on emotional manifestations of anxiety and compulsiveness in rats","authors":"A. Lebedev, V. V. Lukashkova, A. G. Pshenichnaya, E. Bychkov, V. Lebedev, Vladimir V. Rusanovsky, P. Shabanov","doi":"10.17816/rcf492319","DOIUrl":"https://doi.org/10.17816/rcf492319","url":null,"abstract":"Background. In recent years, the role of orexins and their receptors in the regulation of the emotions, motivations and brain reinforcing systems has been studied. Orexin is an important regulator of the extrahypothalamic system of corticotropin-releasing hormone. This provides grounds for the search for new pharmacological agents for the treatment of phobic spectrum disorders among drugs that modulate orexin regulation. \u0000Aim: To analyze the effect of the new OX1R antagonist Antorex on the emotional manifestations of anxiety in rats. \u0000Methods. Experiments were performed on 38 Wistar male rats. Behavior was tested in rats; Antorex 1 g/l (or water) with a volume of 20 l (10 l in each nostril) was intranasally administered. To achieve this goal, a battery of behavioral tests was used: elevated plus maze, open field, marble test, intruder-resident test and anxiety-phobic state assessment. \u0000Results. In the elevated plus maze test, Antorex showed moderate anxiolytic activity, increasing the time spent in the light arm compared to control animals. In a marble test, after Antorex administration, a decrease in the number of buried balloons was observed, as a reflection of a decrease in the obsessive-compulsive state of anxiety. In the anxiety-phobic state assessment test, a decrease in the avoidance reaction to the action of the hand was registered. In the \"open field\" test, a decrease in motor activity was observed. \u0000Conclusion. The OX1R antagonist Antorex has an anxiolytic and sedative effect reducing compulsive behavior without affecting the communicative activity. The data obtained provide grounds for the development of new approaches to the treatment of phobic spectrum disorders using drugs that modulate orexin regulation.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79868096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of the influence of peptide bioregulators on the resistance of the organism to adverse effects 多肽生物调节剂对机体抗不良反应能力影响的研究
Pub Date : 2023-06-14 DOI: 10.17816/rcf456396
A. E. Kim
The article is devoted to the prospects of using peptide bioregulators-cytomedins to increase the body's resistance to adverse environmental influences. Scientific publications on the general mechanisms of action of peptide bioregulators, the main clinical effects and applications, the results of studying their activity in individuals with signs of asthenia and reduced immunoreactivity under conditions of hypoxia, hyperthermia, exposure to aviation and space flight factors, deep-sea diving, and a complex of factors of the Arctic zone were analyzed. It has been shown that under the conditions of a single intranasal administration in low doses, the use of cortexin, epithalamin, thymogen and prostatilen contributes to an increase in the tolerance of adverse effects, and their short course use is characterized by the presence of delayed positive effects, reflecting the effect of drugs on the level of nonspecific resistance of the organism. The specific features of the action of individual drugs depend on the type of adverse effect and the organ tropism of the drug.
本文介绍了利用多肽生物调节剂-细胞蛋白来增强机体对不利环境影响的抵抗力的前景。本文分析了肽类生物调节剂的一般作用机制、主要临床效果和应用,以及在缺氧、高热、暴露于航空和航天飞行因素、深海潜水和北极地区复杂因素等条件下对虚弱和免疫反应性降低个体活性的研究结果。研究表明,在低剂量单次鼻内给药的情况下,皮质素、上皮素、胸腺素和前列腺素的使用有助于增加对不良反应的耐受性,并且它们的短期使用的特点是存在延迟的积极作用,反映了药物对生物体非特异性耐药水平的影响。个别药物作用的具体特征取决于不良反应的类型和药物的器官趋向性。
{"title":"Study of the influence of peptide bioregulators on the resistance of the organism to adverse effects","authors":"A. E. Kim","doi":"10.17816/rcf456396","DOIUrl":"https://doi.org/10.17816/rcf456396","url":null,"abstract":"The article is devoted to the prospects of using peptide bioregulators-cytomedins to increase the body's resistance to adverse environmental influences. Scientific publications on the general mechanisms of action of peptide bioregulators, the main clinical effects and applications, the results of studying their activity in individuals with signs of asthenia and reduced immunoreactivity under conditions of hypoxia, hyperthermia, exposure to aviation and space flight factors, deep-sea diving, and a complex of factors of the Arctic zone were analyzed. It has been shown that under the conditions of a single intranasal administration in low doses, the use of cortexin, epithalamin, thymogen and prostatilen contributes to an increase in the tolerance of adverse effects, and their short course use is characterized by the presence of delayed positive effects, reflecting the effect of drugs on the level of nonspecific resistance of the organism. The specific features of the action of individual drugs depend on the type of adverse effect and the organ tropism of the drug.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75704454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circular RNAs - modern view on the molecular mechanism of neurologic diseases of the human. Prospects of search of new therapeutic agents 环状rna——人类神经系统疾病分子机制的现代观点。寻找新的治疗药物的前景
Pub Date : 2023-06-12 DOI: 10.17816/rcf334925
P. Shabanov, V. I. Vashchenko, L. Savelieva, Yuliia E. Romashova
In mammals, many classes of noncoding RNAs (ncRNAs) are expressed at a much higher level in the brain than in other organs. Recent studies have identified a new class of ncRNAs called circular RNAs (circRNAs), which are produced by back-splicing and fusion of either exons, introns, or both exon-intron into covalently closed loops. The circRNAs are also highly enriched in the brain and increase continuously from the embryonic to the adult stage.Although the functional significance and mechanism of action of circRNAs are still being actively explored, they are thought to regulate the transcription of their host genes and sequestration of miRNAs and RNA binding proteins. Some circRNAs are also shown to have translation potential to form peptides. The expression and abundance of circRNAs seem to be spatiotemporally maintained in a normal brain.Altered expression of circRNAs is also thought to mediate several disorders, including brain-tumor growth, and acute and chronic neurodegenerative disorders by affecting mechanisms such as angiogenesis, neuronal plasticity, autophagy, apoptosis, and inflammation. These extraordinary peculiarities make circRNAs potentially suitable as promising molecular biomarkers, especially of neurodegenerative diseases. This review represents generalisation of the new data about circRNAs, underlining their role in a pathogenesis of the basic neurodegenerative disorders: emphasizing their role in pathogenesis of major neurodegenerative disorders, Alzheimers disease, frontotemporal dementia, and Parkinsons diseases, schizophrenia diseases, ALS with a look toward their potential usefulness in biomarker searching.
在哺乳动物中,许多种类的非编码rna (ncRNAs)在大脑中的表达水平比在其他器官中要高得多。最近的研究发现了一类新的ncRNAs,称为环状rna (circRNAs),它是通过外显子、内含子或外显子-内含子的反剪接和融合形成共价闭环而产生的。circrna在大脑中也高度富集,并且从胚胎到成年阶段不断增加。尽管circRNAs的功能意义和作用机制仍在积极探索中,但它们被认为可以调节宿主基因的转录和microrna和RNA结合蛋白的分离。一些环状rna也被证明具有翻译形成多肽的潜力。环状rna的表达和丰度在正常大脑中似乎是时空维持的。circRNAs表达的改变也被认为通过影响血管生成、神经元可塑性、自噬、细胞凋亡和炎症等机制介导多种疾病,包括脑肿瘤生长、急性和慢性神经退行性疾病。这些非凡的特性使得环状rna可能适合作为有前途的分子生物标志物,特别是神经退行性疾病。这篇综述概述了关于环状rna的新数据,强调了它们在基本神经退行性疾病发病机制中的作用:强调了它们在主要神经退行性疾病、阿尔茨海默病、额颞叶痴呆、帕金森病、精神分裂症、ALS发病机制中的作用,并展望了它们在生物标志物搜索中的潜在用途。
{"title":"Circular RNAs - modern view on the molecular mechanism of neurologic diseases of the human. Prospects of search of new therapeutic agents","authors":"P. Shabanov, V. I. Vashchenko, L. Savelieva, Yuliia E. Romashova","doi":"10.17816/rcf334925","DOIUrl":"https://doi.org/10.17816/rcf334925","url":null,"abstract":"In mammals, many classes of noncoding RNAs (ncRNAs) are expressed at a much higher level in the brain than in other organs. Recent studies have identified a new class of ncRNAs called circular RNAs (circRNAs), which are produced by back-splicing and fusion of either exons, introns, or both exon-intron into covalently closed loops. The circRNAs are also highly enriched in the brain and increase continuously from the embryonic to the adult stage.Although the functional significance and mechanism of action of circRNAs are still being actively explored, they are thought to regulate the transcription of their host genes and sequestration of miRNAs and RNA binding proteins. Some circRNAs are also shown to have translation potential to form peptides. The expression and abundance of circRNAs seem to be spatiotemporally maintained in a normal brain.Altered expression of circRNAs is also thought to mediate several disorders, including brain-tumor growth, and acute and chronic neurodegenerative disorders by affecting mechanisms such as angiogenesis, neuronal plasticity, autophagy, apoptosis, and inflammation. These extraordinary peculiarities make circRNAs potentially suitable as promising molecular biomarkers, especially of neurodegenerative diseases. This review represents generalisation of the new data about circRNAs, underlining their role in a pathogenesis of the basic neurodegenerative disorders: emphasizing their role in pathogenesis of major neurodegenerative disorders, Alzheimers disease, frontotemporal dementia, and Parkinsons diseases, schizophrenia diseases, ALS with a look toward their potential usefulness in biomarker searching.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84790154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Reviews on Clinical Pharmacology and Drug Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1